CIMIT is the first — and only — organization focused solely on bringing clinicians, engineers and scientists together; encouraging them to collaborate and find innovative technological solutions to important healthcare problems; and supporting them at every step of the way, from concept through implementation.
Focused in the areas of greatest opportunity for technology to make transformational change in the current paradigm of patient care, CIMIT Science Programs offer an insider’s view of the future of medicine — where and how technology has the potential to transform healthcare in the not-too-distant future. Below are some innovative examples of the many initiatives that CIMIT is supporting.
NOTES: Natural Orifice Translumenal
Endoscopic Surgery
In early 2008, CIMIT awarded its $2.1 million Strategic Project to the NOTES initiative lead by Dr. David Rattner and Dr. Christopher Thompson. The award of $700,000 annually for three years represents CIMIT’s largest grant program. With this award, CIMIT’s investment in NOTES research will top $3 million overall, making CIMIT the largest financial sponsor of this technology worldwide to advance the CIMIT's mission of emphasizing minimally invasive approaches.
Inhalation TechnologyThe project, called the Inhalation Technology Program, will be developed over three years. Acute respiratory infections are the third largest cause of death worldwide. The goal of the Inhalation Technology Program is to develop technologies to facilitate inhalation therapy that will help reduce human suffering and eventually health care costs. Read press release.
Of The Futures
Medical Device Plug-and-Play
SimulationCIMIT's Simulation Program is focused on creating realistic training tools so that doctors, medics and first responders can practice on mannequins in a simulated trauma setting. This dual use program — supporting both civilian and soldier medicine — recently received a $2 million grant from the U.S. Army to continue its efforts in developing tools that will be used for trauma training.